Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Anticancer Research
|
January 1, 1997
The reversal of multidrug resistance in multicellular tumor spheroids by SDZ PSC 833
P H Ehrlich, Z A Moustafa, A E Archinal-Mattheis, et al.
Oncology Research
|
January 1, 1995
Analysis of the interactions of SDZ PSC 833 ([3'-keto-Bmt1]-Val2]-Cyclosporine), a multidrug resistance modulator, with P-glycoprotein
A Archinal-Mattheis, R W Rzepka, T Watanabe, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 11, 2001
Identification of E2F-1/Cyclin A antagonists
S K Sharma, T M Ramsey, Y N Chen, et al.
Journal of Medicinal Chemistry
|
March 26, 1999
Structural and conformational requirements for high-affinity binding to the SH2 domain of Grb2(1)
P Ettmayer, D France, J Gounarides, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 14, 1999
Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists
Y N Chen, S K Sharma, T M Ramsey, et al.
The Journal of Organic Chemistry
|
March 23, 2001
Bengamides revisited: new structures and antitumor studies
Z Thale, F R Kinder, K W Bair, et al.
Anti-Cancer Drugs
|
August 1, 1991
Phase I evaluation of 773U82.HCl, a member of a new class of DNA intercalators
K A Havlin, J G Kuhn, J B Craig, et al.
Cancer Research
|
December 1, 1990
Phase I and clinical pharmacology trial of 502U83 using a monthly single dose schedule
D D Von Hoff, J G Kuhn, K A Havlin, et al.
The Journal of Organic Chemistry
|
April 13, 2001
Total syntheses of bengamides B and E
F R Kinder, S Wattanasin, R W Versace, et al.
Journal of Medicinal Chemistry
|
October 19, 2001
Synthesis and antitumor activity of ester-modified analogues of bengamide B
F R Kinder, R W Versace, K W Bair, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Anticancer Research
|
January 1, 1997
The reversal of multidrug resistance in multicellular tumor spheroids by SDZ PSC 833
P H Ehrlich, Z A Moustafa, A E Archinal-Mattheis, et al.
Oncology Research
|
January 1, 1995
Analysis of the interactions of SDZ PSC 833 ([3'-keto-Bmt1]-Val2]-Cyclosporine), a multidrug resistance modulator, with P-glycoprotein
A Archinal-Mattheis, R W Rzepka, T Watanabe, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 11, 2001
Identification of E2F-1/Cyclin A antagonists
S K Sharma, T M Ramsey, Y N Chen, et al.
Journal of Medicinal Chemistry
|
March 26, 1999
Structural and conformational requirements for high-affinity binding to the SH2 domain of Grb2(1)
P Ettmayer, D France, J Gounarides, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 14, 1999
Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists
Y N Chen, S K Sharma, T M Ramsey, et al.
The Journal of Organic Chemistry
|
March 23, 2001
Bengamides revisited: new structures and antitumor studies
Z Thale, F R Kinder, K W Bair, et al.
Anti-Cancer Drugs
|
August 1, 1991
Phase I evaluation of 773U82.HCl, a member of a new class of DNA intercalators
K A Havlin, J G Kuhn, J B Craig, et al.
Cancer Research
|
December 1, 1990
Phase I and clinical pharmacology trial of 502U83 using a monthly single dose schedule
D D Von Hoff, J G Kuhn, K A Havlin, et al.
The Journal of Organic Chemistry
|
April 13, 2001
Total syntheses of bengamides B and E
F R Kinder, S Wattanasin, R W Versace, et al.
Journal of Medicinal Chemistry
|
October 19, 2001
Synthesis and antitumor activity of ester-modified analogues of bengamide B
F R Kinder, R W Versace, K W Bair, et al.
Page
of 2